SIDHARTH CHANDRA: Open Payments
NPI 1295140143 · ELDORADO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,780 in 109 payments from 12 companies in 2025. Trend: 2023 $1,139 · 2024 $1,076 · 2025 $2,780
Food & beverage: $2,773Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $1,535 |
| Otsuka America Pharmaceutical, Inc. | 13 | $213 |
| Alkermes, Inc. | 11 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $169 |
| Janssen Pharmaceuticals, Inc | 9 | $168 |
| Neurocrine BioSciences, Inc. | 6 | $138 |
| Braeburn Inc. | 4 | $85 |
| Vanda Pharmaceuticals Inc. | 5 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $59 |
Products named: VRAYLAR, ARISTADA, CAPLYTA, INGREZZA, SPRAVATO, REXULTI, BRIXADI, FANAPT.
Industry payments across IL — which companies pay providers there.
